NCT03849872View on ClinicalTrials.gov

Single-dose Study to Evaluate the Absolute Bioavailability and Mass Balance of ONO-5788

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 27, 2019

Primary Completion Date

April 2, 2019

Study Completion Date

April 2, 2019

Conditions
Acromegaly
Interventions
DRUG

ONO-5788

Investigational Drug

DRUG

[14C]-ONO-5788

Investigational Drug

Trial Locations (1)

9728

PRA-EDS, Groningen

Sponsors
All Listed Sponsors
lead

Ono Pharmaceutical Co. Ltd

INDUSTRY

NCT03849872 - Single-dose Study to Evaluate the Absolute Bioavailability and Mass Balance of ONO-5788 | Biotech Hunter | Biotech Hunter